Introduction
In the past 40 to 50 years, biologists working on a variety of organisms have provided the context to understanding human birth defects and disease. Just as biology is the foundation of medicine, evolution is the foundation of biology. Thus, evolutionary sciences are in a position to profoundly inform our understanding of human disease. Take cancer, for example: cancer does not respect ethnicity, or gender [1] . That all of us can be potentially fated to experience this disease speaks to the common thread of genetic ancestry shared by all humans. This in turn reflects a common gene toolkit that underlies the complex physiology and body plans of nearly all animals. In fact, our health and disease states are but the latest manifestations of the long and ongoing process of evolution -a combination of random mutation and drift, natural selection (Box 1), and in the particular case of humans, even social engineering.
Whether extant or extinct, all organisms share a common attribute: variation. Such variation represents the collective genetic history of each population and, in turn, reflects the evolutionary forces that shaped both the species and the individuals within each population. Therefore, one must attempt to understand the extent by which historical evolutionary processes, such as selection and drift, have affected the mechanistic intricacies of our extant physiological and pathological states. For example, recent findings for a role in the regeneration of lost body parts for proteins generally associated with human cancers [2] [3] [4] have prompted a reexamination of the evolutionary origins of the functions of these molecules. Resolving the perplexing fact that, despite possessing a common gene toolkit, origin organisms, such as planarians, flies, nematodes and many other species, do not seem to display the same frequency or evidence of cancer [5] should be of great importance in understanding the causes/origins and mechanisms of this disease.
As more and more data are being accumulated on the genomics of cancers [6, 7] , the functions of so-called 'cancer genes' in diverse, less studied animal species might provide not only new insights on how the functions of such genes may have naturally evolved, but also shed light on our mechanistic understanding of the disease itself. In this review, I will attempt to illustrate the need for simultaneously considering the roles of microevolution, macroevolution (Box 1), development, and social engineering on biological systems when interrogating the causes and mechanisms of disease, particularly those driven by excessive cellular proliferation such as cancer. I will also suggest that by simultaneously considering the retrospective nature of evolutionary developmental biology and the prospective forces of microevolution and population genetics, it becomes possible to investigate the complexities of present-day human cancers, and re-examine basic concepts, such as tumor suppression, as well as the model organisms currently being used to study this and other human disorders.
The Prospective Power of Microevolution
Based on a population of 6 billion people and a mutation rate of 2 3 10 28 per base pair, Kruglyak and Nickerson [8] calculated that, in the most recent human generation, every possible mutation that is compatible with life will have occurred an average of 240 times. This rapid rate of change in the allele frequencies of a population is known as microevolution (Box 1) [9] . That microevolutionary principles can help explain the incidence, pathology and characteristics of many human diseases has not gone unnoticed by the medical community [10] [11] [12] . This is particularly evident in studies in which population genetics have been applied to uncover the causes of disease susceptibility in human populations [13] [14] [15] [16] [17] [18] . One intriguing and insightful application of microevolutionary principles to the study of cancer was recently put forward by Greaves and Malley [7] . They describe how the inherent complexity of 'tissue ecosystems' in humans provides fertile ground for the appearance of genetic variation in otherwise clonally identical populations of cells. This variation effectively leads to rapid rates of change in allele frequencies in the different cell populations. In the case of cancers, increase in variation results in the production of subclones which themselves are subjected to microevolutionary processes resulting in complex lineage and branching evolutionary trajectories ( Figure 1A) . In other words, it appears as if the ontogeny of some forms of human cancers can be explained using microevolutionary principles. At this level of analysis, the appearance of cellular diversity in tumors is not dissimilar to the appearance of variation in animal populations ( Figure 1B) . Consider, for example, the wing pattern variation observed in Heliconiusa butterfly endemic to the tropics of South America -which is associated with different genomic rearrangements that lock together distinct genetic elements involved in wingpattern formation [19] . Such rearrangements have allowed Heliconius to generate adaptive wing patterns according to geographic ecosystem variation [20] . Thus, understanding first principles of how variation is introduced into a population of either cells or animals that allow measurements of mutation, selection, genetic drift and flow can, in principle, inform essential aspects of cancer biology, such as the sequence of events that lead to the progression of a tumor, or whether a given mutation does or does not provide a proliferative (reproductive) advantage to a cancerous cell, and most importantly, help predict the outcomes of artificial selection (therapeutic intervention) such as resistance to chemotherapy.
Macroevolution and the Force of Retrospection
Studies of macroevolutionary transitions (Box 1) can illuminate the emergence of species and variation across and within taxa. When new attributes such as multicellularity emerge allowing organisms to venture into new environments, adaptive radiations follow, provided they encounter little or no competition [21, 22] . Interestingly, multicellularity has been associated with the evolutionary appearance of genes known to be involved in tumor formation in humans. It has been proposed that cancer in humans is an evolutionary legacy [23, 24] . Yet, studies on whether tumors can form in basal animals have not been extensive [25, 26] . Moreover, given the remarkable differences between the molecular nature of tumor suppressors in invertebrates, such as Drosophila melanogaster, and vertebrates, such as humans and mice [5] , the formal possibility remains that genes responsible for cancer may have emerged independently through convergent evolution. [7] . (B) Morphological diversity of wing patterns in Heliconius butterflies [64] . Recent molecular evidence shows that the many adaptive multi-locus polymorphisms seen in this butterfly arise from chromosomal reorganization of a co-adaptive gene set found in a chromosomal interval of about 400 kb [19] .
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Microevolution: changes in gene frequency within a population, which can generally be observed over short periods of time. Such changes may occur due to at least four different processes: Mutation: changes in DNA sequence, introduced during DNA replication (cell division). Natural and/or artificial selection: Natural genetic variants may sometimes be advantageous (positive selection), or deleterious (negative selection) to the survival and/or reproductive output of an individual, leading to changes in the frequency of genetic variants. This process is called natural selection. Selection applied by humans to plants and animals [71, 72] is called 'artificial selection', and can be illustrated by the remarkable gamut of physical and behavioral features displayed by the more than 350 breeds thus far obtained by pigeon breeders [73] . Genetic drift: As DNA mutates and phenotypic changes are introduced and selected, and variation in the population increases, random events eventually come into play to determine which genetic changes will be maintained (fixed), or lost from the population. This random sampling is called genetic drift, and leads over time to changes in the relative frequency of gene variants (alleles) in a given population. In contrast to natural selection, in which reproductive success makes alleles more or less common, changes introduced by genetic drift are independent of reproductive or adaptive pressures and thus need not be benign or malignant. Gene flow: Another force affecting microevolution is gene flow, i.e., the addition or removal of gene variation by either immigration or emigration of individuals to and from a population. Consequently, migrations can have marked effects on allele frequency by modulating the genetic variation of an established gene pool. Macroevolution: changes that occur at or above the level of species. While microevolution can be readily applied to the study of individual species and can be aimed prospectively to predict allele frequencies, and to some extent evolutionary outcomes within a population, microevolution alone is insufficient to explain large-scale changes across multiple populations and geological time scales. Retrospective studies aimed at understanding the origins of genes, genomes and by extension species and phyla are, instead, the domain of macroevolution. Although most, if not all, of the microevolutionary causes that drive variation within a species apply to macroevolution [74] , the fundamental difference between them is scale. Rather than looking within a species and within that species' lifetime, macroevolution focuses on the general forces driving the evolution of species across millions of years. Disciplines such as paleontology [75] , comparative genomics [76] [77] [78] , evolutionary developmental biology [79] , and more recently genomic phylostratigraphy [27, 80, 81] , contribute the lion's share of evidence for macroevolution.
Recent phylostratigraphic tracking -a statistical approach for reconstructing macroevolutionary trends -of genes that when mutated are thought to participate in tumor formation and development, however, is beginning to provide robust macroevolutionary evidence for the ancient origins of cancer [27] .
Comparison of the human cancer genes deposited in four databases (COSMIC [28] , Entrez section in CancerGenes, CancerGenes proper [29] and Network of Cancer Genes [30] ) against the genome sequences of organisms arranged according to their phylogenetic relationships uncovered a clear, statistically significant relationship between the likely point of emergence of metazoans and the appearance of genes we presently associate with cancer [27] . It is remarkable that in the transition between Holozoa (represented by the unicellular choanoflagelates) and early metazoans (represented by poriferans), there is a statistically significant overrepresentation of the genes found in the four cancer databases (Figure 2 ). Whether these genes are involved in tumor suppression and/or formation in these organisms remains largely unknown, but as we will see below, evidence from functional studies of invertebrates, such as the planarian Schmidtea mediterranea, are beginning to illuminate this question [2, 4] . If, as the macroevolutionary evidence suggests, the genes that cause cancer today have an ancient evolutionary origin, it becomes clear that our present reliance on about a handful of model systems from only two branches of the animal tree of life (Deuterostomes and Ecdysozoans) may be severely limiting our ability to mechanistically understand cancer and many other human diseases.
Development and Heritable Variation
While microevolution can tell us much about relatively rapid changes within a population, and macroevolution illuminates the slow changes at or above the species level, developmental biology allows us to understand individuals. From the very moment an egg is fertilized, through its gastrulation, growth, maturity and death, development provides the context in which genes and the environment interact to produce all individuals in any given population. Hence, nowhere are the intertwined threads of microevolution, macroevolution and the environment more saliently displayed than during development. Evolutionary and developmental biologists follow development to understand the history, function and malfunctions of the individual. This approach, however, took nearly a hundred years to mature. Confronted with a myriad of developmental strategies used by embryos to become fully grown animals ( Figure 3A) , developmental biologists in the late 19 th century such as August Weismann [31] and T.H. Morgan [32] postulated that biological diversity arises from changes in gene functions, while evolutionary biologists like Bateson would argue that the selection of variation [33] was, in fact, truly responsible for the diversity found in biological systems [34] . Such explanatory disparities arose from analyzing the same problem (heritable variation) from different levels of analysis (genes vs. adaptations), and yielded many unproductive debates [35] . Resolving this quandary would require first a synthesis of meiosis, recombination and genetics, and the advent of molecular biology ( Figure 3B ). This integrative approach, in turn, has allowed developmental biologists to launch an unprecedented exploration of development and evolution at multiple levels of analysis that has resulted in and continues to yield spectacular insights into our understanding of life.
Developmental genetics also has identified genes that can cause sudden changes in adult morphology [36] , and thus are capable of introducing phenotypic variation into a population [37] . Hence, much effort has been invested in recent years to understand the functional relationships among genes, and between genes and the environment in developmental systems. As these functional relationships begin to emerge, it is becoming quite clear that, at any time during the life of an organism, a single gene can participate in countless regulatory events [38] . Such complexity is robustly supported by the work on gene regulatory networks (GRNs) that have been defined based on studies of sea urchin embryogenesis ( Figure 3C ). The application of this methodology to both sea urchin and Drosophila embryogenesis, for example, has revealed that mutations affecting cis-regulatory nodes of a GRN are associated with the gain, loss, or co-option of regulatory genes, which then may alter the architecture of a GRN and change developmental outcomes [39] [40] [41] [42] .
In some ways, the state of cancer research today can be likened to the state in which developmental biology found itself at the beginning of the 20 th century: disparate explanations arising from different levels of analysis which are hard to reconcile in the absence of an integrative approach. Therefore, efforts to understand a disease as complex as cancer at the dawn of the 21 st century by only looking at the genes that cause it, without taking into consideration micro-and macroevolutionary forces, should strike us as incomplete. It should also be readily apparent that the [27] .) The colored arrows indicate significant over-representation of cancer genes at these specific phylogenetic positions (for a complete list of the phylostrata positions please consult [27] ). ) in a vegetative view of the marine scaphopod mollusk Dentalium embryo (adapted from [65] ); invariant lineages of the cephalopod endosymbiont dycemid mesozoan embryo (adapted from [66] ); rear view of a 6 hour 15 min Nereis embryo (a marine, polychaete worm) depicting cell lineages of the various blastomeres [67] ); chromosome diminution in Ascaris embryos (small fragments in division plane, large blastomere, middle) as described by Theodor Boveri in 1910 [68] (images kindly supplied by Dr J.G. Gall). (B) Cyril Darlington's schema integrating fertilization, recombination and genetics to explain the connection between genetics and the physical entity of chromosomes (adapted from [69] ). (C) The most recent gene regulatory network of sea urchin primary mesenchyme cells (PMCs) at 6-30 hours of development [70] .
regulatory networks associated with so-called cancer genes need to be elucidated both under normal physiological conditions across the entire gamut of development as well as disease states in multiple model systems. Otherwise, a likely outcome for the biomedical sciences will be to repeat history and engage in unproductive debates about the cause of disease not too different from those held by biologists at the beginning of the 20 th century about the nature of variation. More than ever, the causes of health and disease need to be looked at through analyses at multiple levels of inquiry.
P53 and the Evolution of Tumor Suppression
Cellular proliferation needs to be regulated to ensure the survival of multicellular organisms, and therefore, mechanisms for regulating tumor suppression are likely to have ancestral evolutionary origins. Yet, the vast efforts invested in understanding protein functions alone as a means to discover therapeutic targets to combat cancer has skewed current thinking on the biology of tumor suppression. PTEN, P53 and RB -the three tumor suppressor proteins most commonly mutated in human tumors [43] -are not tumor suppressors in invertebrate model systems such as Drosophila and C. elegans, and the genes acting as tumor suppressors in the fly (e.g., scribbled, lethal giant larvae, discs large) do not appear to be tumor suppressors in mammals [44] [45] [46] [47] . Therefore, it has become widely accepted that the tumor suppression functions of proteins such as P53 may have arisen recently in mammalian evolution from an ancestral role of this protein in DNA-damage sensing or DNA repair [48] .
Moreover, the differences in life-span and size between the model invertebrate and vertebrate model systems used to study tumor suppression do not help to simplify matters. Take Peto's paradox, for example [49] , which essentially states that if all mammalian cells are equally susceptible to oncogenic mutations and have equivalent tumor suppression capacities, then the number of cells that can become malignant in a given organism would be directly proportional to the number of cells and life-span of the organism. In other words, under these conditions the probability of a blue whale living a cancer-free life would be less than w2.27 3 10
253
[50]. However, cancer incidence does not scale with body size or longevity across species [50, 51] . If it did, whales would die before they could reproduce and thus would have become extinct long ago [52] . Because mammals alone can differ close to a million-fold in size [51] and a hundredfold in maximum life span [53] , the obvious issue raised by Peto's paradox is that large, long-lived animals such as whales and elephants are suppressing tumors much more efficiently than we humans are.
Given that all biological attributes arise from micro-and macroevolutionary trends on the one hand, and through interactions between genes and the environment during development on the other, why should tumor suppression be exempt from these forces? The perplexing differences in the functions and numbers of proteins functioning as tumor suppressors in different animals likely reflect a tortuous evolutionary history for these molecules across different phyla. The paleostratigraphic data (Figure 2 ) clearly indicate that many of our simpler multicellular ancestors already possessed a large cohort of genes which can be associated with cancer [27] . In fact, the closest unicellular relative to multicellular animals, the choanoflagellate Monosiga brevicollis, has a homolog to both p53 and p63 ( Figure 4A) . If, as generally believed, p53 acquired its tumor suppression function in vertebrates [48] , and also became duplicated in vertebrates to control stem cell self-renewal [54] , what could the function of this family of proteins be in a unicellular organism? These types of macroevolutionary analyses highlight two very important points. First, dissecting the functions of the p53 family of proteins in a single-celled animal such as Monosiga promises to be immensely informative to our understanding of the evolution of the tumor suppressor activity of these proteins. Determining what roles p53 and/or p63 may play in the proliferation and formation of colonies in choanoflagelates, for instance, should provide mechanistic insight into the normal, physiological, and ancestral functions possessed by these proteins. And second, a better understanding of cancer suppression mechanisms necessitates the mechanistic interrogation of a much more evolutionarily diverse cohort of organisms than those being currently investigated.
Until recently, there has been no functional study of a p53 family member in an invertebrate that has very high requirements for adult tumor suppression, nor of a member of the Lophotrochozoa ( Figure 4A ). One such organism is the planarian Schmidtea mediterranea (Figure 4B ), because of its remarkable developmental plasticity a model system for stem cell biology, regeneration and tissue homeostasis [55] . S. mediterranea has a single p53 homolog called Smed-p53, whose expression is largely restricted to the newly made progeny of stem cells [4] (Figure 4B ). RNAi of Smed-p53 results in an increase in stem cell number and proliferation at the expense of daughter cell differentiation, consistent with Smed-p53 having tumor suppressor-like function in planarians ( Figure 4C ). Moreover, as the Smedp53 loss-of-function phenotype progresses, a terminal depletion of the stem cell population is observed, suggesting that this molecule may also function similarly to vertebrate p63. Smed-p53 is the first invertebrate p53-family member shown to have a role in stem cell proliferation control, selfrenewal and lineage specification. Altogether, these studies support the conclusion that an ancestral p53-family member was already functioning in stem cell biology and proliferation control, and that these functions were not vertebrate inventions. Furthermore, it is interesting to note that planarian P53 and other vertebrate tumor suppressor proteins such as PTEN [2] are involved in this organism's ability to temporarily allow their stem cells to hyper-proliferate after injury. Such activity raises the very intriguing possibility that what we refer to as tumor suppression may simply be an ancestral molecular mechanism responsible for surveying changes in the environment (i.e., loss of tissues to amputation) in order to orchestrate the appropriate proliferative and cellular differentiation responses required by such changes (i.e., wound repair and regeneration). Participation in such physiological repair mechanisms may in fact be the main, evolutionarily selected function of tumor suppressors in vertebrates.
Conclusion
The notion that complex diseases, such as cancer, may have ancient evolutionary origins opens the door to the exploration of this problem in evolutionarily diverse organisms. By studying animals, such as planarians, in which gene function can be readily perturbed in the adult condition (thus bypassing embryonic lethality), it should be possible to test multiple hypotheses in a relatively short period of time and hence spur the discovery of fundamental, evolutionarily conserved mechanisms not only underpinning diseases associated with hyperproliferation, such as cancer, but also mechanisms that modulate cell proliferation during biological processes such as regeneration and degeneration.
Equally, if not more importantly, all such studies aimed at understanding complex biological functions and malfunctions must integrate a synthesis of microevolution, macroevolution, genetics and developmental biology. For instance, a re-examination under this light of the mammalian model systems presently used to study human disease seems warranted. Given the effects that inbreeding, artificial selection and the environment can have on organisms in as little as one generation, such conditions ultimately become an integral part of the experimental model itself. In fact, mice under standard laboratory conditions are generally sedentary, have constant access to food, are provided with little to no stimulation and have been shown to be metabolically morbid [56, 57] . In studies of tumor induction, standard control rodents were shown to develop more spontaneous tumors than mice that ate less [58, 59] . Thus, experiments in which such mice are used as controls will confound the analyses of essential aspects of cancer biology such as the correct elucidation of the sequence of events that lead to the progression of the disease, or whether a given mutation does or does not provide a proliferative advantage to a cancerous cell. More alarmingly, such mice can negatively skew the outcomes of therapeutic interventions, and negatively affect outcome predictions of human studies. The fact that the vast majority of cancer drugs tested in over 500 phase II clinical trials and shown to be effective in preclinical standard rodent models proved ineffective in humans should make us take pause [60] .
Finally, given Peto's paradox, rather than looking at mouse models with a high predisposition to cancer, would it not be equally important to look at mouse strains that may be, in fact, resistant to cancer? Mouse species of feral origins such as Mus spretus and Mus castaneus have been reported to have low tumor incidence [61] , and F1 hybrids of M. spretus and Mus musculus tolerated chemical carcinogenesis protocols, and failed to develop tumors in most tissues tested [62] . Understanding the genetic composition of such variation in the mouse population, and the GRNs associated with this apparent resistance to cancer should help determine the extent to which tumor inhibition is regulated by microevolutionary and/or developmental forces. Alternatively, would it not be beneficial for studies of tumor suppression to develop cell lines from elephants, whose genome appears to contain at least 12 copies of p53? In sum, if human health and disease are to cease perplexing us, it seems unavoidable that understanding their respective causes necessitates both retrospective and prospective biological studies, an effort that will require continued research with established model organisms [63] , the development of numerous, evolutionarily diverse model systems, and the simultaneous deployment of multiple disciplines at multiple levels of inquiry.
